产品名称
Serine/Threonine Kinase Inhibitor Set, The Serine/Threonine Kinase Inhibitor Set controls the biological activity of Serine/Threonine Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
desiccated (hygroscopic)
protect from light
solubility
DMSO: 1 mg/mL (all other inhibitors)
water: 1 mg/mL (Protein Kinase G Inhibitor)
shipped in
ambient
storage temp.
−20°C
Quality Level
Biochem/physiol Actions
Cell permeable: yes
Primary Target
PKA
PKA
Secondary Target
PKC, MLCK, Cam kinase II, PKG
PKC, MLCK, Cam kinase II, PKG
Disclaimer
Toxicity: Multiple Toxicity Values, refer to MSDS (O)
General description
A convenient set that offers several highly selective serine/threonine kinase inhibitors. Kinases play an important role in numerous signaling cascades. Highly selective protein kinase inhibitors are useful for dissecting these cascades to determine which specific kinases are involved in producing particular biological effects. The Serine/Threonine Kinase Inhibitor Set contains the following highly selective serine/ threonine kinase inhibitors in one convenient set:
• Bisindolylmaleimide I (Cat. No. 203290), 250 µg
• H-89, Dihydrochloride (Cat. No. 371963), 1 mg
• KN-93 (Cat. No. 422708), 1 mg
• ML-7 (Cat. No. 475880), 1 mg
• Protein Kinase G Inhibitor (Cat. No. 370654), 1 mg
• Staurosporine (Cat. No. 569397), 100 µg
• Bisindolylmaleimide I (Cat. No. 203290), 250 µg
• H-89, Dihydrochloride (Cat. No. 371963), 1 mg
• KN-93 (Cat. No. 422708), 1 mg
• ML-7 (Cat. No. 475880), 1 mg
• Protein Kinase G Inhibitor (Cat. No. 370654), 1 mg
• Staurosporine (Cat. No. 569397), 100 µg
Other Notes
Martiny, G., et al. 1993. J. Biol. Chem.268, 9194.
Toullec, D., et al. 1991. J. Biol. Chem.266, 15771.
Chijiwa, T., et al. 1990. J. Biol. Chem.265, 5267.
Simu, M., et al. 1991. Biochem. Biophys. Res. Commun.181, 968.
Saitoh, M., et al. J. Biol. Chem.262, 7796.
Glass, D.B., et al. 1983. Biochem. J.213, 159.
Seynaeve, C.M., et al. 1994. Mol. Pharmacol.45, 1207.
Meyer, T., et al. 1989. Int. J. Cancer43, 851.
Toullec, D., et al. 1991. J. Biol. Chem.266, 15771.
Chijiwa, T., et al. 1990. J. Biol. Chem.265, 5267.
Simu, M., et al. 1991. Biochem. Biophys. Res. Commun.181, 968.
Saitoh, M., et al. J. Biol. Chem.262, 7796.
Glass, D.B., et al. 1983. Biochem. J.213, 159.
Seynaeve, C.M., et al. 1994. Mol. Pharmacol.45, 1207.
Meyer, T., et al. 1989. Int. J. Cancer43, 851.
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions of each inhibitor are stable for up to 3 months at -20°C.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 4 - Repr. 2
存储类别
11 - Combustible Solids
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持